Skip to main content
. 2021 Dec 10;8:790091. doi: 10.3389/fmolb.2021.790091

TABLE 1.

Characteristics of participants with T2DM.

Well-controlled group (n = 8) Poorly-controlled group (n = 16) p-value
Age (years) 65.25 ± 3.77 69.69 ± 5.51 0.053
Gender(F/M) 7/1 13/3 1.000
Tooth number (count) 26.13 ± 2.30 25.38 ± 2.96 0.750
PPD (mm) 3.27 ± 0.49 3.45 ± 0.44 0.376
AL (mm) 2.39 ± 0.81 3.12 ± 1.04 0.096
BI 2.31 ± 0.88 2.41 ± 0.65 0.756
BOP (+) 0.71 ± 0.27 0.68 ± 0.26 0.815
HbA1c (%) 6.31 ± 0.40 7.79 ± 1.55 0.002*
FPG (mmol/L) 5.93 ± 0.42 8.62 ± 1.52 0.000**
CHOL (mmol/L) 4.86 ± 1.03 4.78 ± 1.14 0.997
TG (mmol/L) 1.64 ± 0.60 1.50 ± 0.82 0.658
HDL (mmol/L) 1.59 ± 0.18 1.37 ± 0.25 0.039
LDL (mmol/L) 2.64 ± 0.96 2.69 ± 0.85 0.835
CRP (mmol/L) 1.39 ± 1.45 2.17 ± 2.10 0.357

Data were described as mean ± SD. PPD, probing pocket depth, Al, attachment level; BI, bleeding index; HbA1c, glycated hemoglobin; FPG, fasting plasma glucose; CHOL, cholesterol; TG, triglyceride; HDL, high-density lipoprotein; LDL, low-density lipoprotein.

*Statistically significant difference (student’s t test, p-value < 0.05).

**Statistically significant difference (student’s t test, p-value < 0.001).